Edition:
United States

Dicerna Pharmaceuticals Inc (DRNA.OQ)

DRNA.OQ on NASDAQ Stock Exchange Global Select Market

11.95USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$11.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
80,379
52-wk High
$12.25
52-wk Low
$2.52

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.47 -0.919
Jun '17 0.25 -1.154
Mar '17 0.13 -0.683
FY 2016 Dec '16 0.13 -0.676
Sep '16 0.16 -0.683
Jun '16 0.00 -0.754
Mar '16 0.00 -0.760
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 2.45 2.90 2.00 --
Quarter Ending Jun-18 2 2.45 2.90 2.00 --
Year Ending Dec-18 5 6.90 12.00 0.00 3.30
Earnings (per share)
Quarter Ending Mar-18 2 -0.81 -0.75 -0.87 --
Quarter Ending Jun-18 2 -0.83 -0.75 -0.91 --
Year Ending Dec-18 4 -3.11 -2.59 -3.75 -2.10
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 189.80 34.75
P/E High - Last 5 Yrs. -- 284.12 46.00
P/E Low - Last 5 Yrs. -- 92.89 24.22
Beta 2.23 0.81 0.81
Price to Sales (TTM) 622.10 135.24 8.23
Price to Book (MRQ) -- 20.37 5.26
Price to Tangible Book (MRQ) 8.55 28.60 6.43
Price to Cash Flow (TTM) -- 126.27 26.16
% Owned Institutions 86.04 11.97 2.26

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.51
Dividend Yield - 5 Year Avg -- 0.20 2.02
Dividend 5 Year Growth Rate -- 1.92 5.22
Payout Ratio(TTM) -- 8.39 43.43

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 192.59 63.69 9.79
Sales (TTM) vs TTM 1 Yr. Ago 512.35 63.80 7.60
Sales - 5 Yr. Growth Rate -48.20 33.26 10.22
EPS (MRQ) vs Qtr. 1 Yr. Ago -34.47 -99.96 17.74
EPS (TTM) vs TTM 1 Yr. Ago -20.44 -- --
EPS - 5 Yr. Growth Rate -- 46.90 11.61
Capital Spending - 5 Yr. Growth Rate -2.17 42.29 14.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.43
Current Ratio (MRQ) 7.59 5.76 3.39
LT Debt to Equity (MRQ) 0.00 16.49 12.05
Total Debt to Equity (MRQ) 0.00 18.61 15.44
Interest Coverage (TTM) -- -166.79 38.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.28 54.71
Gross Margin - 5 Yr. Avg. -- 55.52 52.58
EBITD Margin (TTM) -5,857.86 -- --
EBITD - 5 Yr. Avg -2,548.91 -236.98 14.67
Operating Margin (TTM) -5,936.90 -474.87 4.61
Operating Margin - 5 Yr. Avg. -2,601.61 -253.74 9.99
Pre-Tax Margin (TTM) -5,895.26 -449.94 5.35
Pre-Tax Margin - 5 Yr. Avg. -2,654.52 -260.30 10.27
Net Profit Margin (TTM) -5,895.26 -445.34 1.86
Net Profit Margin - 5 Yr. Avg. -2,654.52 -263.73 6.57
Effective Tax Rate (TTM) -- 0.42 21.98
Effective Tax Rate - 5 Yr. Avg. -- 18.01 24.18

Efficiency

  Company industry sector
Revenue/Employee (TTM) 21,106 23,891,213 828,235,197
Net Income/Employee (TTM) -1,244,277 -630,600 96,880,046
Receivable Turnover (TTM) -- 14.32 5.42
Inventory Turnover (TTM) -- 2.43 3.50
Asset Turnover (TTM) 0.01 0.39 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -80.29 -1.01 10.70
Return on Assets - 5 Yr. Avg. -65.97 -0.24 12.05
Return on Investment (TTM) -93.32 -0.65 13.63
Return on Investment - 5 Yr. Avg. -74.68 2.39 15.78
Return on Equity (TTM) -289.17 -3.21 15.25
Return on Equity - 5 Yr. Avg. -403.08 -1.55 17.01
  1 Year 3 Year 5 Year
Sales % 60.33 -- -48.20
EPS (TTM) % 7.12 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Dicerna Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 5.80 11.13 80 55
13 Week 21.82 17.12 72 93
26 Week 292.49 255.11 98 88
52 Week 288.51 240.20 96 88
YTD 27.35 26.05 81 91
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 85.06%
# of Holders: 63
Total Shares Held: 43,926,898
3 Mo. Net Change: 26,526,745
# New Positions: 22
# Closed Positions: 7
# Increased Positions: 37
# Reduced Positions: 14
# Net Buyers: 23
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.